Cargando…

Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor

High-affinity IL-2-R correspond to a membrane receptor complex composed of two different IL-2-binding proteins, the Tac antigen (alpha chain) and a 70-75 kD beta chain. Using cell lines that express either the alpha or the beta protein, we demonstrate that IL-2 internalization occurs when ligand is...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1987
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188578/
https://www.ncbi.nlm.nih.gov/pubmed/3031195
_version_ 1782146441317187584
collection PubMed
description High-affinity IL-2-R correspond to a membrane receptor complex composed of two different IL-2-binding proteins, the Tac antigen (alpha chain) and a 70-75 kD beta chain. Using cell lines that express either the alpha or the beta protein, we demonstrate that IL-2 internalization occurs when ligand is bound to the isolated beta chain, but not when it is bound to the isolated alpha chain. The kinetics of IL-2 internalization mediated by the intermediate-affinity beta chain were nearly identical to those of the high-affinity alpha/beta heterodimer (t1/2 of 10-15 min), and each type of receptor targeted the bound IL-2 for intracellular degradation in lysosomes. The beta chain thus appeared to provide the essential element necessary for ligand internalization by both types of IL-2-R.
format Text
id pubmed-2188578
institution National Center for Biotechnology Information
language English
publishDate 1987
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21885782008-04-17 Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor J Exp Med Articles High-affinity IL-2-R correspond to a membrane receptor complex composed of two different IL-2-binding proteins, the Tac antigen (alpha chain) and a 70-75 kD beta chain. Using cell lines that express either the alpha or the beta protein, we demonstrate that IL-2 internalization occurs when ligand is bound to the isolated beta chain, but not when it is bound to the isolated alpha chain. The kinetics of IL-2 internalization mediated by the intermediate-affinity beta chain were nearly identical to those of the high-affinity alpha/beta heterodimer (t1/2 of 10-15 min), and each type of receptor targeted the bound IL-2 for intracellular degradation in lysosomes. The beta chain thus appeared to provide the essential element necessary for ligand internalization by both types of IL-2-R. The Rockefeller University Press 1987-04-01 /pmc/articles/PMC2188578/ /pubmed/3031195 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor
title Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor
title_full Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor
title_fullStr Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor
title_full_unstemmed Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor
title_short Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor
title_sort internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188578/
https://www.ncbi.nlm.nih.gov/pubmed/3031195